// App-Quantinova.ai

: Randomized Trial between Histidine-tryptophan-Ketoglutarate [HTK] and Institute of Georges Lopez [IGL-1] Perfusion Solutions in Living Donor Liver Transplantation [LDLT]

Researchers

Presenter

  • M. Michael

Principal Investigators

  • L.S. Raju

  • J.S. Mathew

  • B. S T

  • U. Gopalakrishnan

  • D. Balakrishnan

  • R. Menon

  • S. Othiyil Vayoth

  • S. SURENDRAN

Medical Centers

  • Dept. of GI Surgery and Solid Organ Transplant, Amrita Institute of Medical Sciences, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • tryptophan

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved